Skip to main content

Table 3 Diagnosis, and treatment of Kawasaki disease shock syndrome and Kawasaki disease

From: Clinical aspects for differential diagnosis of Kawasaki disease shock syndrome: a case control study

  KDSS(n=13) KD(n=91) P value
Diagnosis
 Initial diagnosis of KD 23.1% (3/13) 80.2% (73/91) 0.000
 Complete KD 46.2% (6/13) 67.0% (61/91) 0.214
 Incomplete KD 38.5% (5/13) 29.7% (27/91) 0.532
Treatment
 1st IVIG 84.6% (11/13) 98.9% (90/91) 0.041
 2nd IVIG 76.9% (10/13) 19.8% (18/91) 0.000
 Oral prednisolone 7.7% (1/13) 11.0% (10/91) 1.000
 Methylprednisolone pulse therapy 38.5% (5/13) 11.0% (10/91) 0.020
 Infliximab 15.4% (2/13) 0.0% (0/91) 0.015
 Antibiotics 92.3% (12/13) 15.4% (14/91) 0.000
  1. IVIG Intravenous immunoglobulin, KD Kawasaki disease, KDSS Kawasaki disease shock syndrome, SS Septic shock and toxic shock syndrome